Metraipolis › archive › dc_5ca6140af8e5
Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors? — Europe PMC PMID:42142195
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42142195
- DOI
- 10.1007/s11060-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T05:36:19.580Z
- SHA-256 of the archived text
ce25892e21e62245e1d96c3e564e6507c112d28a9e9fdaa17dba0dd9eb7f4ff3- Stable URL of this page
https://metraipolis.com/documento/dc_5ca6140af8e5
How to cite
Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors? — Europe PMC PMID:42142195 — Europe PMC (en), https://europepmc.org/article/MED/42142195 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ca6140af8e5 (Metraipolis archive dc_5ca6140af8e5, sha256 ce25892e21e62245e1d96c3e564e6507c112d28a9e9fdaa17dba0dd9eb7f4ff3)
BibTeX
@misc{dc5ca6140af8e5,
title = {Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors? — Europe PMC PMID:42142195},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42142195},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ca6140af8e5; sha256 ce25892e21e62245e1d96c3e564e6507c112d28a9e9fdaa17dba0dd9eb7f4ff3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42142195. Agents can read the archived copy with the MCP tool read_document.